Segmental 18F-FDG-PET/CT in a single pulmonary nodule: a better cost/effectiveness strategy Marco SpadaforaLeonardo PaceLuigi Mansi Editorial 03 October 2016 Pages: 1 - 4
How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol Roland Hustinx Reply 13 September 2016 Pages: 5 - 7
[18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches Evelyn E. C. de JongWouter van ElmptAnne-Marie C. Dingemans Original Article Open access 06 September 2016 Pages: 8 - 16
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235 Jose G. BazanFenghai DuanBilly W. Loo Jr Original Article 19 September 2016 Pages: 17 - 24
PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique Wei GuoBing HaoLong Sun Original Article Open access 22 July 2016 Pages: 25 - 32
Pretreatment tumor SUVmax predicts disease-specific and overall survival in patients with head and neck soft tissue sarcoma Seung Cheol HaJungsu S. OhSang Yoon Kim Original Article 23 July 2016 Pages: 33 - 40
Evaluation of bone-seeking novel radiotracer 68Ga-NO2AP-Bisphosphonate for the detection of skeletal metastases in carcinoma breast Averilicia PassahMadhavi TripathiChandrasekhar Bal Original Article 25 July 2016 Pages: 41 - 49
Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation Christos SachpekidisJ. HillengassA. Dimitrakopoulou-Strauss Original Article 29 August 2016 Pages: 50 - 62
Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer Mathieu GauthéMarion Richard-MolardAstrid Lièvre Original Article 09 August 2016 Pages: 63 - 70
The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma Peter S. N. van RossumDavid V. FriedSteven H. Lin Original Article Open access 11 August 2016 Pages: 71 - 80
177Lu-DKFZ-PSMA-617 therapy in metastatic castration resistant prostate cancer: safety, efficacy, and quality of life assessment Madhav Prasad YadavSanjana BallalChandrasekhar Bal Original Article 10 August 2016 Pages: 81 - 91
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT Johannes SchwenckHansjoerg RemppChristian la Fougère Original Article 24 August 2016 Pages: 92 - 101
Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience Lino M. SawickiChristian BuchbenderHubertus Hautzel Short Communication 21 March 2016 Pages: 102 - 107
Editorial: Listen to your belly, fat is not your foe! Jörg KotzerkeKlaus Zöphel Editorial Commentary 12 October 2016 Pages: 108 - 109
Metabolic and morphological measurements of subcutaneous and visceral fat and their relationship with disease stage and overall survival in newly diagnosed pancreatic adenocarcinoma Christophe Van de WieleMathias Van VlaenderenAlex Maes Original Article 11 October 2016 Pages: 110 - 116
SPECT myocardial blood flow quantitation toward clinical use: a comparative study with 13N-Ammonia PET myocardial blood flow quantitation Bailing HsuLien-Hsin HuTao-Cheng Wu Original Article 01 September 2016 Pages: 117 - 128
Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals Sang-Geon ChoKi Seong ParkHee-Seung Bom Original Article 28 September 2016 Pages: 129 - 140
Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression Philip JosephAmorina IshaiAhmed Tawakol Original Article 13 October 2016 Pages: 141 - 150
Characterization of PET/CT images using texture analysis: the past, the present… any future? Mathieu HattFlorent TixierDimitris Visvikis Review Article 06 June 2016 Pages: 151 - 165
177Lu-PSMA-617 radioligand therapy of mCRPC: evaluation criteria of response Kambiz RahbarMartin BögemannHojjat Ahmadzadehfar Letter to the Editor 04 October 2016 Pages: 166 - 167
Reply to Rahbar K et al. Madhav Prasad YadavSanjana BallalChandrasekhal Bal Reply 01 October 2016 Pages: 168 - 169
Do paraneoplastic changes in diffuse FDG organ uptake predict relapse? – Wait for confirmation study Regine KlugeLars KurchDirk Hasenclever Letter to the Editor 19 October 2016 Pages: 170 - 171
A rare case of rectal carcinoma and prostate carcinoma with coexistent Paget’s disease mimicking bone metastases in both 18F-FDG and 68Ga PSMA PET/CT Arun SasikumarAjith JoyJayaprakash Madhavan Image of the Month 04 October 2016 Pages: 173 - 173
EANM Springer Prizes awarded at EANM’ 16 Barcelona Society Communications 08 October 2016 Pages: 174 - 175
Erratum to: Performance of cardiac cadmium-zinc-telluride gamma camera imaging in coronary artery disease: a review from the cardiovascular committee of the European Association of Nuclear Medicine (EANM) Denis AgostiniPierre-Yves Marieon behalf of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) Erratum 07 October 2016 Pages: 176 - 176
Erratum to: Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351 Ryuichi HaradaShozo FurumotoNobuyuki Okamura Erratum 13 October 2016 Pages: 177 - 177